1
Four cases of microsporidiosis in myeloid leukemic patients have been already described.
2
Several studies have investigated their potential in the treatment of myeloid malignancies.
3
However, little is known about the role of ADAP in myeloid cells.
4
The first patient was a 50 years woman with acute myeloid leukemia.
5
Three cases of acute myeloid leukemia were reported in the HEC arm.
6
Seven patients were studied following bone marrow transplantation for chronic myeloid leukemia.
7
Recent findings show that BAFF expression is not restricted to myeloid cells.
8
Acute myeloid leukemia and myelodysplastic syndromes represented the most common disease indications.
9
Precise control of myeloid cell activation is required for optimal host defense.
10
They include oncology drugs for melanoma, prostate cancer and acute myeloid leukemia.
11
Two cases of acute myeloid leukemia were reported with the best available therapy.
12
This technique is particularly suited for detecting early signs of the myeloid commitment.
13
Unrelated donor transplantation is a treatment option for older patients with myeloid malignancies.
14
This results in a marked clonal increase in the myeloid mass.
15
The HSPCs also had enhanced expression of key myeloid promoting growth factor receptors.
16
Expression of transcription factor PU.1 may maintain some myeloid-like developmental alternatives until commitment.
